Predicting Drug Resistance Using Deep Mutational Scanning: Article No. 2265

Gur Pines, Reilly Fankhauser, Carrie Eckert

Research output: Contribution to journalArticlepeer-review

5 Scopus Citations


Drug resistance is a major healthcare challenge, resulting in a continuous need to develop new inhibitors. The development of these inhibitors requires an understanding of the mechanisms of resistance for a critical mass of occurrences. Recent genome editing technologies based on high-throughput DNA synthesis and sequencing may help to predict mutations resulting in resistance by testing large mutagenesis libraries. Here we describe the rationale of this approach, with examples and relevance to drug development and resistance in malaria.
Original languageAmerican English
Number of pages13
Issue number9
StatePublished - 2020

NREL Publication Number

  • NREL/JA-2700-76627


  • drug resistance
  • DXR
  • fosmidomycin
  • genome editing
  • sequence to activity mapping


Dive into the research topics of 'Predicting Drug Resistance Using Deep Mutational Scanning: Article No. 2265'. Together they form a unique fingerprint.

Cite this